Introduction {#S1}
============

Obstructive sleep apnoea (OSA) in children is a \"sleep breathing disorder characterised by prolonged partial airway obstruction and/or intermittent complete obstruction that interrupts normal ventilation and normal sleep patterns\" [@R01]. OSA in children is associated with a series of daytime and night time symptoms, such as daytime sleepiness, morning headache, snoring, laboured breathing, restless sleep and nocturnal enuresis [@R02]. Untreated OSA can result in serious cardiovascular, neurocognitive, behavioural and metabolic problems [@R02]. The \"gold standard\" for the diagnosis of OSA is polysomnography even if nocturnal cardiorespiratory sleep study (CRSS) represents a good alternative as an abbreviated diagnostic tool [@R03]. The main risk factors of OSA in children include adenotonsillar hypertrophy, obesity, neuromuscular disorders and craniofacial anomalies [@R03]. The first line therapy for children with OSA is adenotonsillectomy, but it is not universally effective due to multifactorial aetiology of the disease [@R04]. Some authors have suggested the presence of a strong association between sleep breathing disorders and mouth breathing, abnormal placement of the tongue and anomalies in orofacial anatomy [@R05]. The most common craniofacial anomalies reported are retrognathism, maxillary contraction usually associated with unilateral or bilateral cross bite and open bite [@R06]. The potential benefit of an orthodontic approach in patients with OSA and malocclusion was previously described by several authors [@R07]^-^[@R09]. We report our experience on treatment of paediatric OSA with an innovative oral device that we called the \"Sleep Apnea Twin Expander\".

Clinical case {#S2}
=============

Patient: A 5-year-old boy D.S. referred to \"Bambino Gesù\" Children\'s Research Hospital for sleep apnoeas since the age of 30 months. The patient underwent a baseline home nocturnal cardiorespiratory sleep study (CRSS) which revealed moderate OSA with apnoea/hypopnoea index (AHI) of 6 events per hour of sleep and no alteration in oxygen saturation (mean of 98%, minimal 92%). Clinical history revealed poor appetite, no allergies, diurnal and nocturnal mouth breathing, loud snoring and repeated apnoeas during sleep. On physical and ear nose and throat (ENT) examination the patient showed good general conditions, pectus excavatum and patological tonsillar hypertrophy grade III) with no signs of inflammation. The initial extraoral and intraoral photographs are shown in [Figure 1](#F1){ref-type="fig"}. The lateral cephalogram ([Fig. 1](#F1){ref-type="fig"}) showed adenoidal hypertrophy (75% of obstruction) confirmed by fiberoptic evaluation. The cephalometric analysis ([Table I](#T1){ref-type="table"}) showed a class II skeletal malocclusion, increased maxillary-mandibular divergence, reduced rhinopharyngeal and oropharyngeal airway dimension. The quality of life (QOL) of the patient was measured with a questionnaire (OSA-18) [@R10]. The score reported in our patient was 81 which suggested a large impact on QOL for both the patient and parents.

![Pre-treatment extraoral, intraoral photographs, lateral cephalogram.](0392-100X-36-328-g001){#F1}

###### 

Cephalometric analysis. Maxillary and mandibular skeletal assessment: maxillary position in relation to cranial base (SNA angle), mandibular position in relation to cranial base (SNB angle), maxillomandibular sagittal differential (ANB angle). Vertical skeletal assessment: maxillo-mandibular divergence (ANS-PNS/GO-GN angle). Airway dimensions: rhinopharyngeal airway dimension (AD1-PNS), oropharyngeal airway dimension (PAS-PPAS).

                  Pre-treatment   Post-treatment   Normal value
  --------------- --------------- ---------------- --------------
  SNA             73.5            73.4             81.4 ± 1.7
  SNB             66.1            67.1             76.4 ± 1.4
  ANB             7.4             6.3              5.0 ± 1.5
  PNS-ANS/GO-GN   39.8            34.4             29 ± 5.0
  AD1-PNS         7.3             7.9              18.9 ± 5.2
  PAS-PPAS        3.1             4.8              12.0 ± 3.2

Treatment: after multidisciplinary assessment, the child was prescribed a conservative treatment including orthodontic treatment and medical therapy. In order to correct malocclusion, we developed an innovative custom-made device, that we called \"Sleep Apnea Twin Expander\". For development of the device, anatomical impressions and a wax bite registration in maximal intercuspation position and in maximum mandibular protrusion were taken. The device ([Fig. 2](#F2){ref-type="fig"}) is a double plate consisting of two separate elements, an upper fixed and a lower removable. It is a combination between the bite block expander by Mc- Namara [@R11] and twin block appliance by Clark [@R12]. The upper part is a modified bite block palatal expander, consisting of a Hyrax-type screw 10 mm (Philoshopy 1, Lancer) secured to the maxillary arch with a 0.045-inch wire framework imbedded in acrylic covering the buccal, lingual and occlusal surfaces of the deciduous canine and first and second deciduous molars. The acrylic was 2 mm thick at the canines and 7 mm thick at the first and second deciduous molars creating steep inclined planes interlocked at about 70° to the occlusal plane. The lower appliance consisted of removable bite plane of acrylic retained with 0.9-mm ball clasps placed in the mandibular interproximal areas of first and second deciduous molars. The mandible was guided to protrude forward by the inclined planes in acrylic. Reactivation of the advancement was carried out with an adjustable screw mechanism on the lower splint to achieve movement of inclined planes for gradual advancement of the mandible. This appliance allows to carry out palatal expansion and mandibular advancement simultaneously in order to obtain an extension of upper airway area and a possibile improvement of OSA symptoms in a short period. The upper bite block expander was bonded to the maxillary arch with resin reinforced glass ionomer cement (Fuji Ortho, GC America). The mother of the patient was instructed to advance the screw once a day for 30 days. In addition, after one week the patient was instructed to wear the lower device during the night. The otorhinolaringologist prescribed intranasal corticosteroids. The advancement screw on the lower appliance was initially activated at 50% of the maximum mandibular protrusion. Thirty days after the oral device placement, the patient\'s mother referred a reduction of snoring and disappearance of apnoea events. Intraoral examination revealed an expansion of the transverse diameter of the upper jaw and an upper interincisal diastema. The screw of the lower plate was reactivated to increase mandibular advancement until 60% of maximal protrusion, the patient was instructed to wear it 14 hours per day, to stop activations in upper expander and was instructed about nasal breathing exercises. The patient was seen at 4-week intervals for an average of 10 additional months. After four months of orthodontic therapy the patient performed a second home nocturnal CRSS with device in situ in order to evaluate the effectiveness of the occlusal device in reducing apnoea events at night. The CRSS showed the absence of significant apnoeas with oxygen saturation within normal limits (AHI = 0.6; oxygen saturation mean of 98.2%, minimal 94%). After eight months of retention, the upper appliance was removed, and lateral cephalogram was performed. The patient was prescribed to use the device as removable during the night. The comparison between cephalometric analysis pre- and post-orthodontic treatment ([Fig. 3](#F3){ref-type="fig"}, [Table I](#T1){ref-type="table"}) showed an increase in the rhinopharyngeal and oropharyngeal space and a reduction in maxillo-mandibular sagittal and vertical discrepancy. The examination of the patient after orthodontic treatment showed an improvement in face appearance, lip competence and dry lips, and the intraoral view showed a class I malocclusion and reduction of the overjet and open bite ([Fig. 4](#F4){ref-type="fig"}). The OSA- 18 QOL questionnaire administrated to the parents at the end of orthodontic treatment showed that the score was reduced to 20, suggesting a large improvement. ENT assessment at the end of the treatment showed reduction in hypertrophy of palatal tonsils and adenoids to grade II, and with no indication for surgical treatment.

![Sleep Apnea Twin Expander in situ.](0392-100X-36-328-g002){#F2}

![Lateral cephalogram pre- and post-treatment. Cephalometric points used in the analysis of the child. Points: A, A-point; ANS: anterior nasal spine; B: B-point; Gn: gnathion; Go: gonion; N: nasion; PNS: posterior nasal spine; AD1: adenoid inferior; S: sella; PPAS: posterior pharyngeal wall; PAS: anterior pharyngeal wall around gonial angle](0392-100X-36-328-g003){#F3}

![Post-treatment extraoral, intraoral photographs, lateral cephalogram.](0392-100X-36-328-g004){#F4}

Discussion {#S4}
==========

In this case report we describe the successful treatment of moderate OSA with a new oral device in a 5-year-old boy. Although adenotonsillectomy represents the first choice for treatment of OSA in children, we decided to treat him with an orthodontic approach based on the moderate degree of OSA with a normal oxygen saturation index and the possibility of a conservative therapeutic strategy. The Sleep Apnea Twin Expander device was suitable for the patient described because it combined maxillary expansion and mandibular advancement. Orthodontic treatment resulted in an improvement of OSA symptoms through modification of the facial skeletal components. The positive effects of maxillary expansion and mandibular anterior repositioning have been previously described in children [@R07]^-^[@R09]. The rapid maxillary expansion can produce significant increment of the total nasal volume [@R13] and mandibular advancement enlarges the retrolingual space and at the same time promotes lingual advancement during the night [@R07]. These aspects, however, have not been confirmed by literature review because of the limited number of studies and further studies are necessary to examine the effect of orthodontic device in a large sample of paediatric patients [@R14] [@R15].

In our patient, breathing pattern and skeletal improvements were documented: the post-treatment lateral cephalogram showed an increase of rhinopharyngeal and oropharyngeal space, a reduction of maxillo-mandibular sagittal and vertical discrepancy, AHI passed from 6 to 0.6 events/night and the OSA-18 score decreased from 81 to 20. Moreover, a reduction of the adenoidal and tonsillar hypertrophy degree was demonstrated, similar to data reported in a previous study [@R07]. We hypothese that this effect may be related to the enlargement of the upper airway and retropharyngeal spaces that produce a relative reduction of the hypertrophy. The successful therapy of this case confirms the importance of a multidisciplinary approach in diagnosis and therapy of paediatric OSA. The early orthodontic approach, aimed to obtain simultameus palatal expansion of the upper maxillary and the mandibular advancement at the first phase of the treatment, associated with medical and breathing exercises, may modify the skeletal maxillo-mandibular anatomy by preventing obstruction of the upper airway. Considering the results of this case, further studies are warranted to examine the effects of orthodontic treatment with the Sleep Apnea Twin Expander in a large number of paediatric OSA patients with similar craniofacial anomalies.
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